Ardent Health (ARDT) Stock: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$10.98
0.08 (0.73%)
▲
5d:
+2.04%
30d:
-1.08%
90d:
+13.55%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARDT trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ARDT trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.70
Based on 9.7% avg growth
INTRINSIC VALUE TODAY
$9.13
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $10.98, which is considered fair relative to its 30-day fair value range of $10.76 to $11.23. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.8) compared to its historical average (7.4). At these levels, the market is pricing in 5.5% annual earnings growth.
Technical Outlook: Technically, ARDT is in a uptrend. The price is approaching resistance at $11.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.77 (+16.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDT is in a uptrend. The price is approaching resistance at $11.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.77 (+16.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.76 -
$11.23
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($12.77)
- BULLISH: Expecting earnings turnaround to 5.5% growth with -1.4% revenue growth
- NEUTRAL: Bottoming setup forming (54/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$10.76 -
$11.23
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.50
Resistance Level
$11.27
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.75
Wall Street Target
$12.77
(+16.3%)
Revenue Growth (YoY)
-1.4%
Earnings Growth (YoY)
-77.1%
Profit Margin
1.2%
Valuation Premium vs History
+5.5% premium
PE vs Historical
8.8 vs 7.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.5%
(market-implied from PE analysis)
1-Year Target
$11.58
(+6%)
2-Year Target
$12.22
(+11%)
3-Year Target
$12.89
(+17%)
3-Yr Target (if PE normalizes)
(PE: 9→7)
PE COMPRESSION
$10.91
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 15.4%)
$38.90
(+254%)
Base:
(SPY PE: 8.7, Growth: 15.4%)
$16.88
(+54%)
Bear:
(PE: 7.4, Growth: 15.4%)
$14.27
(+30%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 20.57 | Current EPS (TTM): $0.53
Bull Case
$23.98
(+118%)
Analyst growth 100.0%, PE expands to 22.6
Base Case
$21.80
(+99%)
Market implied 100.0%, PE stable at 20.6
Bear Case
$7.41
(-33%)
Severe decline -20.0%, PE contracts to 17.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
